ArticleDiabetes, obesity & metabolism2025
Understanding the clinical characteristics associated with health care costs and cost savings upon weight reduction in individuals with obesity or overweight.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding the clinical characteristics associated with health care costs and cost savings upon weight reduction in individuals with obesity or overweight.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimsThis study aimed to (1) identify characteristics of people with obesity or overweight that are predictive of health care costs; and (2) identify potential subgroups associated with weight reduction and cost savings following weight reduction interventions. MATERIALS AND
methodsThis retrospective cohort study used the Optum MarketClarity database from 2014 to 2022. The primary objective was assessed among individuals ≥19 years old with obesity/overweight with ≥12 months of continuous medical/pharmacy enrolment (primary cohort; index date: date of body mass index [BMI] measure ≥27 kg/m
resultsOutpatient visits, inpatient days, emergency room visits, and Charlson Comorbidity Index were main drivers of health care costs in GLM and RF models. Obesity-related complications (ORCs) including gastroesophageal reflux disease, osteoarthritis-knee and hip, coronary heart disease, hypertension, and heart failure were also influential predictors of cost, associated with approximately 2-4-fold higher median costs. The strongest predictors of cost savings and ≥10% weight reduction were baseline costs, outpatient visits (OMM cohort) and metabolic syndrome (surgery cohort).
conclusionsFindings underscore ORCs as key drivers of health care costs and highlight the need for targeted treatment strategies to effectively manage obesity, reduce the risk and severity of ORCs, and control health care costs. Furthermore, understanding baseline costs and treatment-related cost trajectories across patient subgroups offers critical insights to inform both clinical decision-making and health policy design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.